Trucheck FemmeSafe (Breast, Ovaries, Endometrium, Cervix) is a revolutionary multicancer cancer screening test, from Datar Cancer Genetics, is based on a simple fasting blood draw anywhere in the UK and Ireland. It screens for early detection of common female cancers such as breast cancer, cervical cancer, ovarian cancer, uterine cancer or endometrial cancer. The test is suitable for general health screening and especially for those on HRT as HRT can increase the risk of some female cancers. It is recommended as an annual test.
Click here to learn more from Cancer Research UK about HRT
Risks from HRT depend on many different things including the type of HRT, when people start taking it, how long they take it for, age and general health. The benefits of taking HRT will vary from person to person too. Please talk to your GP or healthcare professional about HRT and how the TruCheck Test could help.